Browse current and past press releases from The Michael J. Fox Foundation.
-
-
The Michael J. Fox Foundation Commits Up to $5.75 Million in Funding For 2010 Critical Challenges in Parkinson's Disease
-
Michael J. Fox Foundation Awards $1.1 Million for Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment for Parkinson's
-
The Michael J. Fox Foundation Awards $3.5 Million to Advance LRRK2 Therapeutic Development Efforts
-
Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinson's Drug Development
-
The Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline
-
Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams' Pre-Clinical Development of Neuroprotective Parkinson's Therapies